Literature DB >> 779705

Methadyl acetate and methadone as maintenance treatments for heroin addicts. A veterans administration cooperative study.

W Ling, C Charuvastra, S C Kaim, C J Klett.   

Abstract

This was a double-blind comparison of methadyl acetate and two dose levels of methadone hydrochloride in the maintenance of 430 street heroin addicts from 12 Veterans Administration hospitals. The starting sample consisted of 146 patients receiving low-dose methadone, 142 patients receiving methadyl acetate. Patients were first given 30 mg of both drugs, and doses were incremented by 10 mg/week until they stabilized at methadyl acetate, 80 mg three times a week, and methadone hydrochloride, 50 mg daily or 100 mg daily. Dosage was fixed for the balance of the 40-week treatment period. Safety was evaluated by clinical and laboratory observations conducted at frequent intervals throughout the study. Relative efficacy was evaluated by illicit drug use, program retention and attendance, and global staff judgments. It is concluded that methadyl acetate is as safe a drug as methadone and that it compares favorably with highdose methoadone in terms of efficacy. Both methyadyl acetate and high-dose methadone appear to be better maintenance regimens than low-dose methadone under the conditions of this study.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 779705     DOI: 10.1001/archpsyc.1976.01770060043007

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  10 in total

1.  Buprenorphine and methadone in the treatment of opioid dependence: methods and design of the COBRA study.

Authors:  Hans-Ulrich Wittchen; Sabine M Apelt; Gerhard Bühringer; Markus Gastpar; Markus Backmund; Jörg Gölz; Michael R Kraus; Felix Tretter; Jens Klotsche; Jens Siegert; David Pittrow; Michael Soyka
Journal:  Int J Methods Psychiatr Res       Date:  2005       Impact factor: 4.035

Review 2.  Methadone maintenance treatment in opiate dependence: a review.

Authors:  M Farrell; J Ward; R Mattick; W Hall; G V Stimson; D des Jarlais; M Gossop; J Strang
Journal:  BMJ       Date:  1994-10-15

Review 3.  Methadone: applied pharmacology and use as adjunctive treatment in chronic pain.

Authors:  R Brown; C Kraus; M Fleming; S Reddy
Journal:  Postgrad Med J       Date:  2004-11       Impact factor: 2.401

4.  On-site Basic Health Screening and Brief Health Counseling of Chronic Medical Conditions for Veterans in Methadone Maintenance Treatment.

Authors:  Ayman Fareed; Dominique Musselman; Johnita Byrd-Sellers; Sreedevi Vayalapalli; Jennifer Casarella; Karen Drexler; Lawrence Phillips
Journal:  J Addict Med       Date:  2010-09       Impact factor: 3.702

Review 5.  Treatment of heroin (diamorphine) addiction: current approaches and future prospects.

Authors:  Gerardo Gonzalez; Alison Oliveto; Thomas R Kosten
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  Consistent adherence to guidelines improves opioid dependent patients' first year outcomes.

Authors:  Jodie A Trafton; Keith Humphreys; Alex H S Harris; Elizabeth Oliva
Journal:  J Behav Health Serv Res       Date:  2007-07-04       Impact factor: 1.505

7.  A meta-analysis of retention in methadone maintenance by dose and dosing strategy.

Authors:  Yan-Ping Bao; Zhi-Min Liu; David H Epstein; Cun Du; Jie Shi; Lin Lu
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

Review 8.  Therapeutic options and challenges for substances of abuse.

Authors:  Tracie J Gardner; Thomas R Kosten
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

Review 9.  Impact of Chronic Pain on Treatment Prognosis for Patients with Opioid Use Disorder: A Systematic Review and Meta-analysis.

Authors:  Brittany B Dennis; Monica Bawor; Leen Naji; Carol K Chan; Jaymie Varenbut; James Paul; Michael Varenbut; Jeff Daiter; Carolyn Plater; Guillaume Pare; David C Marsh; Andrew Worster; Dipika Desai; Lehana Thabane; Zainab Samaan
Journal:  Subst Abuse       Date:  2015-09-10

10.  A call for consensus in defining efficacy in clinical trials for opioid addiction: combined results from a systematic review and qualitative study in patients receiving pharmacological assisted therapy for opioid use disorder.

Authors:  Brittany B Dennis; Nitika Sanger; Monica Bawor; Leen Naji; Carolyn Plater; Andrew Worster; Julia Woo; Anuja Bhalerao; Natasha Baptist-Mohseni; Alannah Hillmer; Danielle Rice; Kim Corace; Brian Hutton; Peter Tugwell; Lehana Thabane; Zainab Samaan
Journal:  Trials       Date:  2020-01-06       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.